Drug repurposing in cancer

Sleire, Linda, Førde, Hilde Elise, Netland, Inger Anne, Leiss, Lina, Skeie, Bente Sandvei, Enger, Per Øyvind·2017·Pharmacological Research
DOI 10.1016/j.phrs.2017.07.013

Cited by (333)

Items 201–300 of 333

  1. Mebendazole preferentially inhibits cilia formation and exerts anticancer activity by synergistically augmenting DNA damage
    Juyeon Hong, Keun Yeong Kwon, Dong Gil Jang, Taejoon Kwon, Haejin Yoon, Tae Joo Park · 2024 · Biomedicine & Pharmacotherapy
  2. Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review
    Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath · 2021 · Molecular Biology Reports
  3. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications
    Po-Wei Su, Bor‐Sen Chen · 2022 · International Journal of Molecular Sciences
  4. An overview of current strategies and future prospects in drug repurposing in tuberculosis
    Dilpreet Singh, Amrinder Singh, Pooja A. Chawla · 2023 · Exploration of Medicine · Retracted
  5. The success story of drug repurposing in breast cancer
    Siddhika Pareek, Yingbo Huang, Aritro Nath, R. Stephanie Huang · 2020 · Elsevier eBooks
  6. Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene
    Jiunn-Chang Lin, Tsang‐Pai Liu, Vivin Andriani, Muhammad Athoillah, Chih‐Yang Wang, Pei‐Ming Yang · 2021 · Journal of Personalized Medicine
  7. Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer
    Annamaria Antona, Marco Varalda, Konkonika Roy, Francesco Favero, Eleonora Mazzucco, Miriam Zuccalà, Giovanni Leo, Giulia Soggia, Valentina Bettio, Martina Tosi et al. · 2022 · Cancers
  8. Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models
    Serala, Karabo, Bai, Jinming, Prince, Sharon · 2024 · Journal of Cellular and Molecular Medicine
  9. Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B
    Chunxue Zhang, Xiaojing Lu, Ting Ni, Qi Wang, Xiaoyan Gao, Xiao Guang Sun, Jian Li, Fei Mao, Jin Hou, Yudong Wang · 2024 · Pharmacological Research
  10. Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines
    André Cristovão, Nelson Andrade, Fátima Martel, Cláudia Silva · 2024 · International Journal of Molecular Sciences
  11. Cubosomes as Delivery System to Repositioning Nitrofurantoin in Breast Cancer Management
    Dina Louis, Christianne Mounir Zaki Rizkalla, Amira Rashad · 2024 · Drug Design Development and Therapy
  12. Effects of primary hypertension treatment in the oncological outcomes of hepatocellular carcinoma
    Víctor López‐López, A Gómez Gómez, Asunción López‐Conesa, Roberto Brusadín, Valentin Cayuela, Albert Caballero-Illanes, Máximo Torres, Ricardo Robles Campos · 2020 · Annals of Translational Medicine
  13. Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells
    Mariana Pires Teixeira, Natalia Ferreira Haddad, Eliza Freitas Passos, Marcelle Novaes Andrade, María Luisa Campos, Joyle Moreira Carvalho da Silva, Camila Saggioro de Figueiredo, Elizabeth Giestal‐de‐Araujo, Denise Pires de Carvalho, Leandro Miranda‐Alves et al. · 2022 · Cancers
  14. Knowledge Mapping of Drug Repositioning’s Theme and Development
    Xiaona Lang, Jinlei Liu, Guangzhong Zhang, Xin Feng, Wenchao Dan · 2023 · Drug Design Development and Therapy
  15. Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer
    Luxitaa Goenka, Biswajit Dubashi, Sandhiya Selvarajan, Prasanth Ganesan · 2022 · American Journal of Clinical Oncology
  16. Computational Drug Repurposing Studies on SARS-CoV-2 Protein Targets
    Guangfeng Zhou, Lance J. Stewart, Gabriella Reggiano, Frank DiMaio · 2020 · ChemRxiv
  17. Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
    Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, Ekene Emmanuel Nweke · 2023 · Frontiers in Genetics
  18. Critical dysregulated signaling pathways in drug resistance: highlighting the repositioning of mebendazole for cancer therapy
    Amin Aliabadi, Seyed Zachariah Moradi, Sadaf Abdian, Sajad Fakhri, Javier Echeverría · 2025 · Frontiers in Pharmacology
  19. An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer
    Zsuzsanna Schelz, Hiba Faroug Muddather, Fatemeh Sheihaki Jaski, Noémi Bózsity, István Zupkó · 2024 · Current Issues in Molecular Biology
  20. Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines
    Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G. Szatmári, Hiba Faroug Muddather, Noémi Bózsity, István Zupkó, Gabriella Spengler · 2024 · Pharmaceutics
  21. A Novel 3D High‐Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer
    Nazanin Karimnia, Amy Wilson, Brittany R. Doran, Jennie Do, Amelia Matthews, Gwo‐Yaw Ho, Magdalena Plebanski, Thomas W. Jobling, Andrew N. Stephens, Maree Bilandzic · 2025 · Advanced Healthcare Materials
  22. Ameliorating Old Drugs with New Tricks in the Nano Realms
    Konika Choudhury, Siddhartha Sankar Ghosh · 2024 · ACS Applied Nano Materials
  23. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in - vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor
    Rahul D. Jawarkar, Magdi E. A. Zaki, Sami A. Al‐Hussain, Aamal A. Al‐Mutairi, Abdul Samad, Vijay Hariram Masand, Vivek Humane, Suraj N. Mali, Abdullah Yahya Abdullah Alzahrani, Summya Rashid et al. · 2024 · Journal of Biomolecular Structure and Dynamics
  24. Molecularly imprinted polymers based on attapulgite and sustained-release properties for 5-FU
    Xinyuan Ji, Zhe Yang, Jiahui Fang, Sheng Hu · 2024 · Colloid & Polymer Science
  25. Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells
    Joana Gonçalves, Sara Pinto, Francisca Carmo, Cláudia Silva, Nelson Andrade, Fátima Martel · 2024 · International Journal of Molecular Sciences
  26. Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer
    Sanaa K. Bardaweel, Rola AlOmari, Rima Hajjo · 2024 · RSC Medicinal Chemistry
  27. Electron attachment to isolated and microhydrated favipiravir
    Barbora Sedmidubská, Thomas F. M. Luxford, Jaroslav Kočišek · 2021 · Physical Chemistry Chemical Physics
  28. Drug Repurposing Opportunities in Cancer
    Popat Kumbhar, Kapil Kole, Arehalli Sidramappa Manjappa, Niraj Kumar Jha, John Disouza, Vandana Bharat Patravale · 2023 · Springer eBooks
  29. Repurposing Antimalarial Drug Mefloquine for Cancer Treatment
    Gautam R. Mereddy, Conor T. Ronayne · 2018 · Translational Medicine
  30. Cytotoxicity and DNA Binding Ability of Two Novel Gold(III) Complexes
    G. Gu, C. Chen, Qingshi Wang, Zhan Gao, Ming Jing Xu · 2019 · Journal of Applied Spectroscopy
  31. Drug repositioning in castration-resistant prostate cancer using systems biology and computational drug design techniques
    Javad Rafiee, Khadijeh Jamialahmadi, Mohammad Javad Bazyari, Seyed Hamid Aghaee‐Bakhtiari · 2024 · Computational Biology and Chemistry
  32. Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers
    Rajan Kumar Tiwari, Shiv Govind Rawat, Siddharth Rai, Ajay Kumar · 2025 · Endocrine
  33. Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles
    Hui Guo, Yuqi Tian, Xing Wu, Liang Tu, Ji‐Kai Liu, Yongsheng Zheng, Rong Huang · 2024 · Bioorganic Chemistry
  34. Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies
    Huang Zeng, Shengyuan Zhang, Hua Nie, Junhao Li, Jiunlong Yang, Yuanbei Zhuang, Yingjie Huang, Miao Zeng · 2024 · Bioorganic Chemistry
  35. Searching for the Holy Grail − Highly Potent Bridged Endoperoxides for Targeted Cancer Therapy
    Mohit K. Tiwari, Tomasz Adam Gośliński · 2024 · Bioorganic Chemistry
  36. Drug repurposing against fucosyltransferase-2 via docking, STD-NMR, and molecular dynamic simulation studies
    Muhammad Atif, Humaira Zafar, Atia‐tul Wahab, Muhammad Iqbal Choudhary · 2024 · PLoS ONE
  37. Computer-Aided Drug Design for Cancer Therapy
    Antoine Daina, Ute F. Röhrig, Vincent Zoete · 2020 · Elsevier eBooks
  38. On the development of B-Raf inhibitors acting through innovative mechanisms
    Luca Pinzi · 2022 · F1000Research
  39. Non-small Cell Lung Cancer Treatment: Current Status of Drug Repurposing and Nanoparticle-based Drug Delivery Systems
    Tugba Gul Inci, Serap Acar, Dilek Turgut‐Balik · 2024 · TURKISH JOURNAL OF BIOLOGY
  40. In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment
    Ezgi Yağmur Tükel, Onur Ateş, Yağmur Kiraz · 2024 · Molecular Biotechnology
  41. Modern vaccines -mRNA based technology- The great hope to eradicate and cure COVID 19
    2020 · Medical & Clinical Research
  42. Angiogenesis: A Therapeutic Target for Cancer
    Neha Atale, Vibha Rani · 2020 · Springer eBooks
  43. Drug Repurposing in Human Cancers
    Gabriele Grassi, Mario Grassi · 2020 · Current Medicinal Chemistry
  44. Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures
    Daniel Osorio, Parastoo Shahrouzi, Xavier Tekpli, Vessela N. Kristensen, Marieke L. Kuijjer · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Computational Drug Repurposing Studies on SARS-CoV-2 Protein Targets
    Guangfeng Zhou, Lance J. Stewart, Gabriella Reggiano, Frank DiMaio · 2020 · ChemRxiv
  46. Delineating Notch1 and Notch2: Receptor‐Specific Significance and Therapeutic Importance of Pinpoint Targeting Strategies for Hematological Malignancies
    Priyadharshini Tamizhmani, Banumathi Balamurugan, Kishore Thirunavukarasu, Shanmugam Velayuthaprabhu, Selvakumar Subramaniam, Thirunavukkarasu Velusamy · 2024 · European Journal Of Haematology
  47. A computational pipeline combining machine learning and molecular simulations identifies repurposed PI3Kα inhibitors from FDA-approved drugs
    Prince Danan Biniyam, Naomi Kayeri, Seth Junior Ayihi, Syed Arslan Haider, Hope Dzitorwoko, Kwabena Adu-Adjei, Michael Osei, Victoria Ohene‐Adu, Portia Frimpong, Clifford Tignangnen Penajah et al. · 2026 · Artificial Intelligence Chemistry
  48. QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
    Rahul D. Jawarkar, Magdi E. A. Zaki, Sami A. Al‐Hussain, Abdullah Yahya Abdullah Alzahrani, Long Chiau Ming, Abdul Samad, Rahul G Ingle, Suraj N. Mali · 2024 · Chemical Physics Impact
  49. Drug repurposing for personalized medicine
    Jahnvi Hora, Nishita Rambhia, Indra Mani · 2024 · Progress in molecular biology and translational science
  50. Anticancer Properties of Antipsychotic Drugs
    Milica Borovčanin, Bojan Stojanović, Milica Dimitrijevic Stojanovic, Bojana Stojanović, Aleksandar Lazovic, Marina M. Mitrović · 2024 · Interdisciplinary cancer research
  51. Nifuratel Induces Triple-Negative Breast Cancer Cell G2/M Phase Block and Apoptosis by Regulating GADD45A
    Yuhang Hou, Hongyun Hao, Yan Yuan, Jing Zhang, Zhengrui Liu, Yimin Nie, Shichang Zhang, Shengtao Yuan, Mei Jun Yang · 2024 · Pharmaceuticals
  52. Phytoactive-Loaded Lipid Nanocarriers for Simvastatin Delivery: A Drug Repositioning Strategy Against Lung Cancer
    Rocío Celeste Gambaro, Cecilia Y. Chain, Sebastián Scioli Montoto, Ailin Moreno, Cristián Huck‐Iriart, María Esperanza Ruiz, José Sebastián Cisneros, Diego German Lamas, Julia Tau, Stephan Gehring et al. · 2025 · Pharmaceutics
  53. Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulation Study
    Duaa Kanan, Tarek Kanan, Berna Doğan, İsmail Erol, Serdar Durdağı · 2025 · ACS Omega
  54. Harnessing the potential of plant biodiversity in health and medicine: opportunities and challenges
    Nawraj Rummun, John H. Malone, Orakanoke Phanraksa, Alexander Kagansky, Mari–Vaughn V. Johnson, Vidushi S. Neergheen · 2020 · Elsevier eBooks
  55. Drug Repurposing for Hematological Malignancies
    Antony Anista Michael, Pavithra Balakrishnan, Thirunavukkarasu Velusamy · 2023 · Springer eBooks
  56. Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening
    Başak Özay, Ezgi Yağmur Tükel, Gizem Ayna Duran, Yağmur Kiraz · 2024 · Analytical Biochemistry
  57. Drug Repurposing in Oncotherapeutics
    Alkesh Patel · 2020 · IntechOpen eBooks
  58. Ivermectin
    Mohd Kamil Hussain, Rashid Ali, Shakir Ahamad, Mohammad Faheem Khan, Mohammad Saquib · 2023
  59. Drug repurposing in oncology: Bridging computational discovery to clinical application
    Sugumar Baskar, N. Rajendra Prasad · 2026 · International Journal of Cancer
  60. Drug Repurposing: A Paradigm Shift in Drug Discovery
    Saravanan Jayaram, Emdormi Rymbai, Deepa Sugumar, Divakar Selvaraj · 2020 · International Journal of Applied Pharmaceutical Sciences and Research
  61. Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
    Vui King Vincent–Chong, Mukund Seshadri · 2021 · Frontiers in Oral Health
  62. Drug Repurposing in Cancer Research: A Bibliometric Analysis from 2012 to 2021
    Elif Burcu Bali · 2022 · Current Cancer Therapy Reviews
  63. Adsorption of Metformin on Graphene Nanoribbons and Application in Treatment of Oral Cancer Using Photothermal Energy
    Nazneen Pathan, Pravin K. Shende · 2023 · Particle & Particle Systems Characterization
  64. Atovaquone exerts its anticancer effect by inhibiting Na+/K+-ATPase ion transport in canine cancer cells
    Yousef Alharbi · 2023 · Veterinary World
  65. Repurposing fluvoxamine as an inhibitor for NUDT5 in breast cancer cell: an in silico and in vitro study
    Sumathi Ramasamy, Kanimozhi Jeyaram, Aathimoolam Narayanan, Sankarganesh Arunachalam, Selvarajan Ethiraj, Sankar Muthumanickam, Boomi Pandian · 2024 · In Silico Pharmacology
  66. Development and validation of a high-throughput screening pipeline of compound libraries to target EMT
    Sven Jonckheere, Joachim Taminau, Jamie Adams, Jef Haerinck, Jordy De Coninck, Jeroen Verstappe, Kato De Clercq, Evelien Peeters, Alexander Gheldof, Eva De Smedt et al. · 2025 · Cell Death and Differentiation
  67. ATP-Ion Complexation and Lithium’s Bioactive Form in Cellular Solutions
    Julián M. Delgado, Peter S. Klein, Sameer Varma · 2025 · Journal of the American Chemical Society
  68. Design, synthesis, computational insights, and evaluation of tetrazole containing donepezil derivatives as antibiofilm, antimicrobial, and anticancer agents with doxorubicin
    Ali Dişli, Engin Aksu, Doğukan Doyduk, Nurdan Akdoğan, Ülker Çuhacı, Neslihan Özadam, Pelin Telkoparan‐Akillilar, Ümit Yırtıcı, Volkan Eyüpoğlu · 2025 · Journal of Molecular Structure
  69. Fungal polysaccharopeptides reduce obesity by richness of specific microbiota and modulation of lipid metabolism
    Xiaojun Li, Peng Chen, Peng Zhang, Yifan Emily Chang, Mingxu Cui, Jinyou Duan · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Computational drug repositioning of bortezomib to reverse metastatic effect of GALNT14 in lung cancer
    Ok‐Seon Kwon, Haeseung Lee, Hyeon‐Joon Kong, Ji Eun Park, Wooin Lee, Seungmin Kang, Seon‐Young Kim, Wankyu Kim, Hyuk‐Jin Cha · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Inhibitory Effects of Doxycycline on Tumor Progression In vitro and on Metastases in Early-Stage Osteosarcoma Xenografts Mice.
    Argyris Costas Hadjimichael, Athanasios F. Foukas, Εvangelia Papadimitriou, Chrysostomi Peristiani, Ioannis Chaniotakis, Alexandros Pergaris, Stamatios E Theocharis, Panagiotis Sarantis, Amanda K. Psyrri, Andreas F. Mavrogenis et al. · 2022 · Research Square
  72. PSMB8 as a Novel Target for AML Therapy: Uncovering Synergistic Potential with PI3K Inhibitors
    Onur Ateş, Yağmur Kiraz · 2025 · International Journal of Advances in Engineering and Pure Sciences
  73. Large Library Docking for Polypharmacology
    Yujin Wu, Seth F. Vigneron, João M. Bráz, Karthik Srinivasan, Elissa A. Fink, Xi-Ping Huang, Xinyu Xu, Harald Huebner, Joseph Y. Kim, Jing Wang et al. · 2026 · Journal of Medicinal Chemistry
  74. Identification of Apixaban as a Potential Inhibitor of the SARS‐CoV‐2 Main Protease: A Multistage Computational Study
    Ahmed M. Metwaly, Bshra Ali A. Alsfouk, Ibrahim M. Ibrahim, Eslam B. Elkaeed, Ibrahim H. Eissa · 2026 · Journal of Chemistry
  75. Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach
    Hriddhi Sarker, Farhad Bin Farid, Marguba Kamrun, Esha Masud, Asif Ahmed, Mamun Miah, Neladre Shaker Roy, Neeraj Kumar, Md Ahad Ali (24092839) · 2026 · PLoS ONE
  76. Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets
    Adrian Salavaty, Sara Alaei, Mirana Ramialison, Peter David Currie · 2022 · Heliyon
  77. A systematic review on Drug Re-profiling/Re-Purposing
    Bharti Sharma, Dinesh Kumar Yadav · 2022 · IARS International Research Journal
  78. CHALLENGES AND OPPORTUNITIES WITH DRUG REPURPOSING: AN EMERGING TECHNIQUE IN DRUGS DISCOVERY
    Sanyogita Harale, Pooja Hupare, Prajakta Ghatage, Vijaya Govande, Omkar Gurav, Sandip Akaram Bandgar, Sachin P. Patil, Dinanath Gaikwad · 2023 · INDIAN DRUGS
  79. AI/ML and drug repurposing in lung cancer: State of the art and potential roles for retinoids
    Gabriele Sala, Davide La Torre, Marco Repetto, Giuseppe Curigliano · 2024 · Elsevier eBooks
  80. Clinical Trials on Repurposed Drugs: An Overview
    Ruchira Patil, Harshad Takate, Gaurav Shanbhag, Harshada Kiran Sonawane, Amruta Prabhakar Padakanti, Naveen Chella · 2024 · Springer eBooks
  81. Breast Cancer Tissues and Organoids BioBank: Constitution, Research Activities and Samples Access
    Lucia Miranda, Luigi Mandrich, Simona Massa, Teresa Nutile, Clotilde Crovella, Ilaria De Rosa, Raffaella Lucci, Filippo De Rosa, Pasquale Somma, Vincenzo Mercadante et al. · 2025 · Organoids
  82. Drug Re-Purposing - Can Anti-Allergy Drugs also be Used to Treat Cancer?
    Georgia Moschou, Caroline H. Topham · 2020 · ACTA SCIENTIFIC MICROBIOLOGY
  83. Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice
    Nicole L. Stott, Didier Dréau, Ian Marriott, Jeanette M. Bennett, Michael J. Turner, Susan Tsivitse Arthur, Joseph S. Marino · 2021 · Biomedicines
  84. Možnosti uporabe protimikrobnih učinkovin pri zdravljenju raka
    Ana Mitrović, Janko Kos · 2022 · Slovenian Medical Journal
  85. Pyrvinium Pamoate Enhances the Anti-cancer Activities of Gemcitabine in Pancreatic Cancer
    Karabo Serala, Jinming Bai, Sharon Prince · 2024 · Preprints.org
  86. Towards New Topical Treatments For Bacterial Infection
    Victoria E. Lee · 2018 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  87. Study of metronomic chemotherapy in cancer patients at a tertiary care center in South India
    Nishitha Shetty, ParaasharR Rai, Dinesh Shet, PareekshithR Rai, Arpitha Shetty · 2019 · Clinical Cancer Investigation Journal
  88. Drug Repurposing in Oncology
    Luxitaa Goenka, Prasanth Ganesan · 2021 · Indian Journal of Medical and Paediatric Oncology
  89. Inhibitory Effects of Doxycycline on Tumor Progression In vitro and on Metastases in Early-Stage Osteosarcoma Xenografts Mice.
    Argyris Costas Hadjimichael, Athanasios F. Foukas, Εvangelia Papadimitriou, Chrysostomi Peristiani, Ioannis Chaniotakis, Alexandros Pergaris, Stamatios E Theocharis, Panagiotis Sarantis, Amanda K. Psyrri, Andreas F. Mavrogenis et al. · 2021 · Research Square
  90. The Role of Subterminal Hydroxyeicosatetraenoic Acids in the Pathogenesis of Cardiac Hypertrophy
    Sherif M. Shoieb · 2021 · ERA: Education and Research Archive (University of Alberta)
  91. The Concept of Repurposing in COVID-19 Infection
    Lata Potey, Anshu R. Dudhe, Dhanashri Mahesh Tumme, Rupesh Dudhea, Prafulla Sabale · 2022 · Coronaviruses
  92. Screening of a FDA-Approved Compound Library Identifies Menadione in Regulating Colon Cancer Programmed Death via MAPK8 Cascades
    Weiwei Song, Liyuan Cao, Lei Ding, Xueqi Ma, Pengfei Gu, Wenbo Wang, Jinli Sun, Wei Mu · 2022 · Research Square
  93. Búsqueda de nuevos fármacos antichagásicos inhibidores de la Tripanotión sintetasa
    Juan I. Alice · 2022
  94. Co-expression network analysis illustrates the importance of driver genes in colorectal cancer diagnosis, prevention, and therapy
    Amirhosein Yari, Habib MotieGhader, Anahita Samadzadeh, Mohammad Amini, Zahra Ebadi, Faranak Gholipour, Ahad Mokhtarzadeh, Behzad Baradaran, Parinaz Tabrizi-Nezhadi, Sajjad Nematzadeh et al. · 2022 · Research Square
  95. Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
    Rajkumar Singh Kalra, Sandeep Singh, Anjana Munshi, Jitender B. Bariwal · 2022 · Frontiers in Oncology
  96. Editorial: Investigating drugs used off-label in various cancers
    Wang Liu, Benyi Li · 2023 · Frontiers in Oncology
  97. Efficacy and Safety of High Dose of Lansoprazole Pretreatment in Patients with Breast Cancer Receiving Neo-Adjuvant Chemotherapy
    Samah Hussein Mohamed, Hagar A. Alagizy, Tarek M. Mostafa, Dalia El‐Afify · 2023 · Journal of Pharmaceutical Research International
  98. ADVANCES AND DEVELOPMENTS IN DRUG REPURPOSING; STATE OF ART
    Sarmad Dheyaa Noori, Mais Al-Hamdani, Amira B. Kassem · 2023 · Bulletin of Pharmaceutical Sciences Assiut
  99. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma
    Abas Sezer, Lejla Mahmutović, Betül Akçeşme · 2023 · Medical Oncology
  100. Co-expression network analysis illustrates the importance of driver genes in colorectal cancer diagnosis, prevention, and therapy
    Amirhosein Yari, Anahita Samadzadeh, Parinaz Tabrizi-Nezhadi, Habib MotieGhader, Zahra Ebadi · 2024 · Research Square